Ontology highlight
ABSTRACT:
SUBMITTER: Yao Y
PROVIDER: S-EPMC5344918 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
Yao Yiran Y Zhang Pei P Wang Jing J Chen Jiaqing J Wang Yong Y Huang Yin Y Zhang Zunjian Z Xu Fengguo F
Frontiers in pharmacology 20170310
As an anticancer agent, irinotecan (CPT-11) has been widely applied in clinical, especially in the treatment of colorectal cancer. However, its clinical use has long been limited by the side effects and potential tissue toxicity. To discriminate the target toxic tissues and dissect the specific response of target tissues after CPT-11 administration in rats, untargeted metabolomic study was conducted. First, differential metabolites between CPT-11 treated group and control group in each tissue we ...[more]